featured
Subcutaneous vs Intravenous Nivolumab for Renal Cell Carcinoma: CheckMate 67T
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Renal Cell Carcinoma Center of Excellence
Visit our Renal Cell Carcinoma Center of Excellence for additional, in-depth coverage.